Frontlight ResearchEarly access
Taking peopleNo phase
Registry study of lymphoma in people living with HIV
Collects data on treatment and outcomes in adults with HIV-related lymphoma.
Key facts
- Who runs it
- Rotkreuzklinikum München gGmbH
- Where
- Cardiff, United KingdomSee the siteAlso in 3 other countries, 5 sites
- Trial code
- Registry title
- A Registry Study on HIV-related Lymphoma
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 25 Aug 2021
- Expected to end
- 31 Aug 2029
- Type of study
- Observational
- Record updated
- 6 April 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with HIV who have been diagnosed with Hodgkin or non-Hodgkin lymphoma since 01.01.2010. It collects data on their disease, treatment and outcome.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Disease stage
- Hodgkin lymphoma or non-Hodgkin lymphoma, proven by tissue or cell tests.
- Biomarker or test result
- HIV infection at the time the lymphoma was diagnosed.
Main reasons for not taking part
- HIV was diagnosed more than 3 months after the lymphoma diagnosis
- For the prospective part: cannot or will not attend follow-up
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma
- HIV-infection at time of lymphoma diagnosis
- Lymphoma diagnosis since 01.01.2010
- Adult patients ≥ 18 years
- Written informed consent
Who cannot take part
- HIV-diagnosis > 3 months after the diagnosis of malignant lymphoma
- Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)
Where in United Kingdom
Also in 3 other countries, 5 sites
- University Hospital of WalesCardiff, United KingdomContact: Emily Hopkins, MDNot yet recruiting
About the trial
What the trial wants to find out
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group
- Plain-language title
- Registry study of lymphoma in people living with HIVGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 6 April 2023